- Predictive and Prognostic Value of sPRR in Patients with Primary Epithelial Ovarian Cancer
Katrin Kreienbring et al, 2016, Analytical Cellular Pathology CrossRef - Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice
Yaya Chu et al, 2017, OncoImmunology CrossRef - In vivo effects of dexmedetomidine on immune function and tumor growth in rats with ovarian cancer through inhibiting the p38MAPK/NF-κB signaling pathway
Qi-Hang Cai et al, 2017, Biomedicine & Pharmacotherapy CrossRef - New insights into antidiabetic drugs: Possible applications in cancer treatment
Vahid Shafiei-Irannejad et al, 2017, Chem Biol Drug Des CrossRef - Ghrelin accelerates the cartilagic differentiation of rabbit mesenchymal stem cells through the ERK1/2 pathway
Nan Ye et al, 2017, Cytotechnology CrossRef - Baicalin potentiates TRAIL-induced apoptosis through p38 MAPK activation and intracellular reactive oxygen species production
Lei Zhang et al, 2017 CrossRef - Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer
Ying Chen et al, 2018, American Journal of Physiology-Cell Physiology CrossRef - Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells
Xiaolu Han et al, 2018, IJMS CrossRef - Overexpression of the lncRNA FER1L4 inhibits paclitaxel tolerance of ovarian cancer cells via the regulation of the MAPK signaling pathway.
Siwei Liu et al, 2018, J Cell Biochem CrossRef - Growth suppression of human oral cancer cells by candidate agents for cetuximab-side effects.
Katsuhiro Uzawa et al, 2019, Exp Cell Res CrossRef - InFlo: a novel systems biology framework identifies cAMP-CREB1 axis as a key modulator of platinum resistance in ovarian cancer
N Dimitrova et al, 2017, Oncogene CrossRef - Two new mixed-ligand coordination polymers based on multi-N chelating ligand inhibit YAP expression and induce caspase-mediated spinal tumor cell apoptosis
Yi Fu Sun et al, 2019, Braz J Med Biol Res CrossRef - LAMC2 regulated by microRNA-125a-5p accelerates the progression of ovarian cancer via activating p38 MAPK signalling
Dongya Zhang et al, 2019, Life Sciences CrossRef - Old drug, new trick: Repurposing metformin for gynecologic cancers?
Terri Febbraro et al, 2014, Gynecologic Oncology CrossRef - Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer
HyeRan Gwak et al, 2017, Mol. Carcinog. CrossRef - Inhibition of CD147 expression promotes chemosensitivity in HNSCC cells by deactivating MAPK/ERK signaling pathway
Chao Ma et al, 2017, Experimental and Molecular Pathology CrossRef - Overexpression of BMPER in Ovarian Cancer and the Mechanism by which It Promotes Malignant Biological Behavior in Tumor Cells
Yong Xi et al, 2020, BioMed Research International CrossRef - Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer
Lacey M. Litchfield et al, 2015, Oncotarget CrossRef - CD83, a Novel MAPK Signaling Pathway Interactor, Determines Ovarian Cancer Cell Fate
Aalia Batool et al, 2020, Cancers CrossRef - Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Kuo-Chang Wen et al, 2020, J Ovarian Res CrossRef - Recycling the Purpose of Old Drugs to Treat Ovarian Cancer.
Mariana Nunes et al, 2020, Int J Mol Sci CrossRef - Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer
Sen Xu et al, 2018, Mol Cancer Ther CrossRef - Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?
Lara S. Lemon et al, 2022, Gynecologic Oncology CrossRef - The Chemosensitizing Role of Metformin in Anti-Cancer Therapy
Zhimin Tang et al, 2021, ACAMC CrossRef - Sera from women with different metabolic and menopause states differentially regulate cell viability and Akt activation in a breast cancer in-vitro model
Laura C. Flores-García et al, 2022, PLoS ONE CrossRef - Role of p38 MAP kinase in cancer stem cells and metastasis
Sriya Kudaravalli et al, 2022, Oncogene CrossRef - Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous Carcinoma
Mariana Nunes et al, 2022, Cancers CrossRef - Targeting the (pro)renin receptor in cancers: from signaling to pathophysiological effects
Xin Ouyang et al, 2022, J Cancer Res Clin Oncol CrossRef - MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy
Yuxi Cheng et al, 2022, Cancers CrossRef - Metformin Improves Ovarian Cancer Sensitivity to Paclitaxel and Platinum-Based Drugs: A Review of In Vitro Findings
Giovanni Tossetta, 2022, IJMS CrossRef - The Antineoplastic Effect of Carboplatin Is Potentiated by Combination with Pitavastatin or Metformin in a Chemoresistant High-Grade Serous Carcinoma Cell Line
Mariana Nunes et al, 2022, IJMS CrossRef - In Vitro Anticancer Activity of Novel Ciprofloxacin Mannich Base in Lung Adenocarcinoma and High-Grade Serous Ovarian Cancer Cell Lines via Attenuating MAPK Signaling Pathway
Michael A. Fawzy et al, 2023, Molecules CrossRef - The Potential Therapeutic Impact of Metformin in Glioblastoma
Multiforme
Mehdi Sanati et al, 2023, CMC CrossRef - Talcum powder induces malignant transformation in normal human primary ovarian epithelial cells
Amy K. HARPER et al, 2023, Minerva Obstet Gynecol CrossRef - Research progress on traditional Chinese medicine-induced apoptosis signaling pathways in ovarian cancer cells
Yu Wang et al, 2024, Journal of Ethnopharmacology CrossRef - Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins
Diana Luísa Almeida-Nunes et al, 2023, IJMS CrossRef - Drug Repositioning for Ovarian Cancer Treatment: An Update
Maria Maddalena Cavalluzzi et al, 2024, ACAMC CrossRef